Nanobiotix licenses cancer treatment to J&J, extending runway
BioPharma Drive: Drug Pricing
JULY 10, 2023
The pharma company will pay $30 million upfront to gain rights to an experimental therapy meant to enhance the anti-tumor effect of radiation.
144 
Taiho and Lung Therapeutics Enter Into an Exclusive License Agreement in Japan for LTI-01, Treatment for Loculated Pleural Effusions
The Pharma Data
NOVEMBER 11, 2020
Lung Tx”) announced today an exclusive license agreement of LTI-01 , a recombinant human single-chain urokinase plasminogen activator, currently under development by Lung Tx for loculated pleural effusions , for the territory of Japan. is an R&D-driven specialty pharma company with a focus on oncology. 12, 2020 11:00 UTC.
Join 15,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Accelerated Approval and Confirmatory Trials: Timing is Everything
The Premier Consulting Blog
OCTOBER 21, 2024
Camidanlumab Tesirine®: This treatment for relapsed or refractory Hodgkin lymphoma faced setbacks in 2022 when the FDA advised against submitting a Biologics License Application (BLA) without a well-underway Phase 3 confirmatory trial, delaying the approval process. For support with your program, please contact us.
Q&A: The IND Journey Phase I – Navigating Success
Advarra
JULY 19, 2022
The sponsor-initiated IND is conducted by a pharma company seeking commercial approval. To get an approved NDA or Biologics License Application (BLA) you must conduct all phases of clinical studies. For more information on form FDA 1572 refer to Frequently Asked Questions – Statement of Investigator (Form FDA 1572).
Moberg Pharma decides on fully guaranteed rights issue of approximately SEK 150 million
The Pharma Data
NOVEMBER 5, 2020
The demand for an effective drug for nail fungus is high and MOB-015 can achieve a unique market position through its high antifungal effect,” says Anna Ljung, CEO of Moberg Pharma.
Women in STEM with Kristina Torfgard
Drug Target Review
SEPTEMBER 5, 2024
However, my goal was all the time to work with drug development in the pharma industry, so I moved on and started that journey in 1992 when I took on a role as Clinical Research Manager at AstraHässle, a mid-size Swedish pharma company. I experienced challenges in cultural differences working with US, UK, Japan, and China.
Scaling Phage Therapy
Codon
FEBRUARY 13, 2024
Phage-based products have been licensed for use as antibacterial agents in the sanitation , food production , and animal health industries. Crucially, it could also make them easier to license as therapeutic agents. There is also a growing body of successful treatments in the U.S., Phage therapies are sold at a pharmacy in Georgia.
Let's personalize your content